Read the Charter Endorse the Charter Started in February 2024, EBC is thrilled to share with you the European Charter for the Responsible Development of Neurotechnologies! With the ultimate goal to promote a culture of stewardship and trust in neurotechnologies, to foster greater wellbeing and sustainable economic growth, and to guide [...]
The European Brain Council was pleased to attend the 33rd European Congress of Psychiatry, organised by the European Psychiatric Association (EPA), which was held on 5-8 April 2025 in Madrid, Spain. The Congress took place under the motto “Towards Real-World Solutions in Mental Health” focusing on the clinical translation and the sharing of good [...]
Read the 2024 Annual report Dear Colleagues, As we enter another important year for the European Brain Council (EBC), we are delighted to take a moment to reflect and celebrate the accomplishments of 2024 through our Annual Report. As EBC’s mandate continues to grow and expand across the national, European and [...]
The EBC Newsletter for March 2025 can be downloaded here.
On March 11, the European Commission presented the much-anticipated Critical Medicines Act, a proposal aimed at strengthening the resilience and autonomy of the EU’s pharmaceutical supply chain. The European Brain Council (EBC) welcomes this initiative as an important step toward a stronger, more innovative, and competitive Health Union, particularly in light of increased geopolitical [...]
The momentum for national brain strategies is stronger than ever. On 18 March 2025, the European Brain Council (EBC) held its annual Brain Awareness Week event, titled “Brain Health Plans Summit: Towards the Establishment of National Brain Plans in Europe and Beyond”. Hosted by MEP Aurelijus Veryga (ECR, LT), Deputy Coordinator of the European [...]
On February 28, marking the 2025 Rare Disease Day, the European Parliament’s Public Health Committee (SANT) kicked off its survey on rare diseases. The purpose of this public consultation is to provide a basis for the forthcoming work of the Committee in bringing a better understanding of the challenges of persons affected by rare diseases and views of [...]
EBC is thrilled to launch the Research Paper resulting from the second phase of the Rethinking Schizophrenia project, which focused on optimising the care pathway. This report, a collaborative effort from the European Brain Council (EBC) and the European Psychiatric Association (EPA), builds directly on the previous 'Beyond the Voices' Policy Report released in [...]
The European Brain Council (EBC), in collaboration with the Institute of Management of Scuola Superiore de Sant'Anna, was very pleased to launch the 'Rethinking Myasthenia Gravis' project on the occasion of EBC's Rare Disease Day event, held on February 20th in Brussels. Rethinking Myasthenia Gravis (MG) is a research-driven project that will offer policy [...]
As a first glimpse into the second phase of the “Rethinking Schizophrenia’ project, this brief policy report provides an introduction to the ‘Optimising the Schizophrenia Care Pathway’ project, as well as the resulting policy recommendations. This report, a collaborative effort from the European Brain Council (EBC) and the European Psychiatric Association (EPA), builds directly [...]
